The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
Topiramate Extended-Release Capsules are bioequivalent to the reference listed drug (RLD), Trokendi XR Extended-Release Capsules of Supernus Pharmaceuticals
Immunology remained AbbVie’s largest and fastest-growing segment, delivering $30.41 billion in global net revenues,
TMS offers new hope to patients suffering from stroke, migraine, neuropathic pain, depression, and other disorders
Sumatriptan injection is indicated in adults for the acute treatment of migraine
Four FDA-approved products strengthen portfolio and reaffirm commitment to global reach
TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
Topiramate is indicated as a treatment of epilepsy and migraine
PfizerForAll works within the existing healthcare system and through a growing network of partners to simplify access via established channels and to close gaps in care
Dr. Reddy's Laboratories has reported total income of Rs. 7,672.7 crores during the period ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
